Clinical Immunology Society (CIS) Annual Meeting / European Hematology Association (EHA) Annual Congress

June 2023

• Results of a Phase 3 Trial of an Oral CXCR4 Antagonist, Mavorixafor, for Treatment of Patients with WHIM Syndrome